Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-Adhoc: SAP SE: SAP sets course for the future with next generation leadership team: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23755/SAP_2011_logo.svg.png
DGAP-Adhoc: SAP SE: SAP sets course for the future with next generation leadership team
DGAP-Adhoc: SAP SE: SAP sets course for the future with next generation leadership team
DGAP-Adhoc: SAP SE: Verjüngtes Führungsteam stellt Weichen für die Zukunft: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23755/SAP_2011_logo.svg.png
DGAP-Adhoc: SAP SE: Verjüngtes Führungsteam stellt Weichen für die Zukunft
DGAP-Adhoc: SAP SE: Verjüngtes Führungsteam stellt Weichen für die Zukunft
DGAP-Adhoc: SAP SE: SAP Pre-Announces Outstanding Third Quarter Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23755/SAP_2011_logo.svg.png
DGAP-Adhoc: SAP SE: SAP Pre-Announces Outstanding Third Quarter Results
DGAP-Adhoc: SAP SE: SAP Pre-Announces Outstanding Third Quarter Results
DGAP-Adhoc: SAP SE: SAP veröffentlicht hervorragende Ergebnisse für das dritte Quartal: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23755/SAP_2011_logo.svg.png
DGAP-Adhoc: SAP SE: SAP veröffentlicht hervorragende Ergebnisse für das dritte Quartal
DGAP-Adhoc: SAP SE: SAP veröffentlicht hervorragende Ergebnisse für das dritte Quartal
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effectshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-News: Infineon: Solid Q2 FY 2024. Prolonged weak demand in major target markets leads to a lowering of the forecast for the fiscal year. Program to strengthen competitiveness starts.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23619/Infineon-Logo.svg.png
EQS-News: Infineon: Solid Q2 FY 2024. Prolonged weak demand in major target markets leads to a lowering of the forecast for the fiscal year. Program to strengthen competitiveness starts.
EQS-News: Infineon: Solid Q2 FY 2024. Prolonged weak demand in major target markets leads to a lowering of the forecast for the fiscal year. Program to strengthen competitiveness starts.
EQS-AGM: Deutsche Telekom AG: Announcement  of the Convening of the General Meeting in Bonn on 10.04.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23604/Telekom_Logo_2013.svg.png
EQS-AGM: Deutsche Telekom AG: Announcement of the Convening of the General Meeting in Bonn on 10.04.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Deutsche Telekom AG: Announcement of the Convening of the General Meeting in Bonn on 10.04.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-Adhoc: SAP SE: SAP Announces Changes to the Supervisory Board: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23755/SAP_2011_logo.svg.png
EQS-Adhoc: SAP SE: SAP Announces Changes to the Supervisory Board
EQS-Adhoc: SAP SE: SAP Announces Changes to the Supervisory Board
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
EQS-News: Infineon with robust Q1 FY 2024. Market environment outside automotive remains weak. Weaker currency and markets are leading to an adjustment of FY 2024 outlook: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23619/Infineon-Logo.svg.png
EQS-News: Infineon with robust Q1 FY 2024. Market environment outside automotive remains weak. Weaker currency and markets are leading to an adjustment of FY 2024 outlook
EQS-News: Infineon with robust Q1 FY 2024. Market environment outside automotive remains weak. Weaker currency and markets are leading to an adjustment of FY 2024 outlook
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150mhttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
EQS-Adhoc: SAP SE: SAP Updates its Ambition 2025 and Announces Transformation Program for 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23755/SAP_2011_logo.svg.png
EQS-Adhoc: SAP SE: SAP Updates its Ambition 2025 and Announces Transformation Program for 2024
EQS-Adhoc: SAP SE: SAP Updates its Ambition 2025 and Announces Transformation Program for 2024
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISShttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
EQS-Adhoc: Infineon Technologies AG: Court-appointed expert submits opinion in the Qimonda legal dispute: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23619/Infineon-Logo.svg.png
EQS-Adhoc: Infineon Technologies AG: Court-appointed expert submits opinion in the Qimonda legal dispute
EQS-Adhoc: Infineon Technologies AG: Court-appointed expert submits opinion in the Qimonda legal dispute
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C. http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percenthttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent
EQS-News: Infineon achieves record revenue and earnings in the 2023 fiscal year and expects further revenue growth to € 17 billion and a Segment Result Margin of 24 percent for 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23619/Infineon-Logo.svg.png
EQS-News: Infineon achieves record revenue and earnings in the 2023 fiscal year and expects further revenue growth to € 17 billion and a Segment Result Margin of 24 percent for 2024
EQS-News: Infineon achieves record revenue and earnings in the 2023 fiscal year and expects further revenue growth to € 17 billion and a Segment Result Margin of 24 percent for 2024
EQS-Adhoc: Deutsche Telekom AG: Board of Management plans higher dividend for 2023 and buy-backs of Deutsche Telekom shares in 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23604/Telekom_Logo_2013.svg.png
EQS-Adhoc: Deutsche Telekom AG: Board of Management plans higher dividend for 2023 and buy-backs of Deutsche Telekom shares in 2024
EQS-Adhoc: Deutsche Telekom AG: Board of Management plans higher dividend for 2023 and buy-backs of Deutsche Telekom shares in 2024
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investmentshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Infineon Technologies AG: Strong performance by Infineon in the June quarter. Outlook for the 2023 fiscal year confirmed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23619/Infineon-Logo.svg.png
EQS-News: Infineon Technologies AG: Strong performance by Infineon in the June quarter. Outlook for the 2023 fiscal year confirmed
EQS-News: Infineon Technologies AG: Strong performance by Infineon in the June quarter. Outlook for the 2023 fiscal year confirmed
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earningshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
EQS-Adhoc: Vantage Towers AG: Delisting of Vantage Towers AG shares from Frankfurt Stock Exchange effective upon the expiry of the 9 May 2023: https://upload.wikimedia.org/wikipedia/commons/thumb/6/63/Vantage_Towers_Logo_07.2021.svg/1024px-Vantage_Towers_Logo_07.2021.svg.png
EQS-Adhoc: Vantage Towers AG: Delisting of Vantage Towers AG shares from Frankfurt Stock Exchange effective upon the expiry of the 9 May 2023
EQS-Adhoc: Vantage Towers AG: Delisting of Vantage Towers AG shares from Frankfurt Stock Exchange effective upon the expiry of the 9 May 2023
EQS-News: Infineon Technologies AG: INFINEON CONCLUDES A SIGNIFICANTLY BETTER-THAN-EXPECTED QUARTER AND AGAIN RAISES ITS OUTLOOK FOR THE CURRENT FISCAL YEAR: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23619/Infineon-Logo.svg.png
EQS-News: Infineon Technologies AG: INFINEON CONCLUDES A SIGNIFICANTLY BETTER-THAN-EXPECTED QUARTER AND AGAIN RAISES ITS OUTLOOK FOR THE CURRENT FISCAL YEAR
EQS-News: Infineon Technologies AG: INFINEON CONCLUDES A SIGNIFICANTLY BETTER-THAN-EXPECTED QUARTER AND AGAIN RAISES ITS OUTLOOK FOR THE CURRENT FISCAL YEAR
EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23